Salarius Pharmaceuticals, Inc.·4

Nov 5, 2:58 PM ET

Arthur David J. 4

4 · Salarius Pharmaceuticals, Inc. · Filed Nov 5, 2021

Insider Transaction Report

Form 4
Period: 2021-11-03
Arthur David J.
DirectorChief Executive Officer
Transactions
  • Award

    Common Stock

    2021-11-03$0.72/sh+7,939$5,700110,186 total
Footnotes (1)
  • [F1]The reporting person voluntarily agreed to receive a percentage of his base salary in issuer shares and receive these shares in lieu of net cash compensation. Shares are purchased at a price determined pursuantto the issuer's Employee Stock Purchase Plan.

Documents

1 file
  • 4
    wf-form4_163613866819461.xmlPrimary

    FORM 4